Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M93.0Revenue $M7.7Net Margin (%)-103.8Z-Score1.5
Enterprise Value $M46.5EPS $-0.4Operating Margin %-104.6F-Score6
P/E(ttm))0Cash Flow Per Share $-0.1Pre-tax Margin (%)-103.8Higher ROA y-yY
Price/Book1.710-y EBITDA Growth Rate %-17.6Quick Ratio11.7Cash flow > EarningsY
Price/Sales6.45-y EBITDA Growth Rate %-14.7Current Ratio11.7Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-21.8Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-23.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M90.3ROI % (ttm)-39.5Gross Margin Increase y-yY

Gurus Latest Trades with VICL

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VICLGeorge Soros 2014-09-30 Sold Out $1.12 - $1.31
($1.24)
$ 1.03-17%Sold Out0
VICLGeorge Soros 2014-06-30 Buy $1.12 - $1.35
($1.19)
$ 1.03-13%New holding, 58179 sh.58,179
VICLJohn Rogers 2013-12-31 Add0.03%$1.015 - $1.49
($1.2)
$ 1.03-14%Add 39.31%7,062,104
VICLJohn Rogers 2013-06-30 Add0.13%$2.93 - $4.22
($3.52)
$ 1.03-71%Add 93.26%5,134,817
VICLJohn Rogers 2013-03-31 Add0.08%$2.91 - $4.26
($3.54)
$ 1.03-71%Add 71.6%2,656,967
VICLJohn Rogers 2012-12-31 Add0.03%$2.74 - $4.32
($3.31)
$ 1.03-69%Add 49.5%1,548,357
VICLJohn Burbank 2012-12-31 Sold Out -0.05%$2.74 - $4.32
($3.31)
$ 1.03-69%Sold Out0
VICLJohn Burbank 2012-09-30 Buy 0.05%$3.3 - $4.58
($3.69)
$ 1.03-72%New holding, 250000 sh.250,000
VICLJohn Rogers 2012-03-31 Add0.01%$3.02 - $4.28
($3.23)
$ 1.03-68%Add 26.34%877,193
VICLJohn Rogers 2011-06-30 Reduce-0.01%$2.88 - $4.81
($3.75)
$ 1.03-72%Reduce -30.97%577,773
VICLJohn Rogers 2010-09-30 Add0.03%$2.21 - $3.86
($3.2)
$ 1.03-68%Add 548.18%795,728
VICLJohn Rogers 2009-06-30 Buy 0.01%$1.95 - $2.76
($2.28)
$ 1.03-55%New holding, 137198 sh.137,198
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VICL is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
VICL John Rogers 2014-09-305,880,7106.510.09+1.48%
VICL George Soros 2014-09-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


VICL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Ramos Anthony AlanVP, Chief Accounting Officer 2014-10-21Sell428$1.18-14.41view
SMITH LAWRENCE RUSSELLVP, Vaccine Research 2014-10-13Sell1,912$1.08-6.48view
BILINSKY IGORSr VP, Corporate Development 2014-10-13Sell1,335$1.08-6.48view
SAMANT VIJAY BPresident & CEO 2014-10-13Sell4,738$1.13-10.62view
SMITH LAWRENCE RUSSELLVP, Vaccine Research 2014-08-26Sell12,500$1.25-19.2view
Ramos Anthony AlanVP, Chief Accounting Officer 2014-08-26Sell12,500$1.25-19.2view
BILINSKY IGORSenior VP, Corporate Dev't 2014-08-26Sell12,500$1.25-19.2view
Ramos Anthony AlanVP, Chief Accounting Officer 2014-07-21Sell428$1.29-21.71view
SAMANT VIJAY BPresident & CEO 2014-07-14Sell4,737$1.17-13.68view
BILINSKY IGORSenior VP, Corporate Dev't 2014-07-11Sell1,335$1.16-12.93view

Press Releases about VICL :

    Quarterly/Annual Reports about VICL:

    News about VICL:

    Articles On GuruFocus.com
    John Rogers Comments on Vical Feb 26 2014 
    Kids Decide on Dolls or Devices - JAKK, Others 70% Off Sep 17 2013 
    comment on VICL Mar 02 2013 
    Weekly CFO Buys Highlight: VICL, EXA, UCBA, YORW, MGI Jan 21 2013 
    Vical Inc. Insiders Boost Shares after Company’s NASDAQ Listing Gets Upgrade Jan 17 2013 
    Two Biotech Stocks to Buy, One to Avoid Jan 09 2012 
    Vical Inc. (VICL) CEO Vijay B Samant buys 1,000 Shares Jan 20 2011 
    Vical Inc. Reports Operating Results (10-Q) Aug 06 2010 
    Vical Inc. Reports Operating Results (10-Q) May 07 2010 
    creiter note on VICL Jan 03 2010 

    More From Other Websites
    Vical Completes Enrollment in Its Therapeutic HSV-2 Vaccine Clinical Trial Dec 11 2014
    Vical Completes Enrollment in Its Therapeutic HSV-2 Vaccine Clinical Trial Dec 11 2014
    Vical to Present at the Piper Jaffray 26th Annual Healthcare Conference Nov 25 2014
    Vical to Present at the Stifel 2014 Healthcare Conference Nov 11 2014
    10-Q for Vical, Inc. Nov 05 2014
    VICAL INC Files SEC form 10-Q, Quarterly Report Nov 03 2014
    Vical Reports Third Quarter 2014 Financial Results and Progress in Key Development Programs Oct 30 2014
    VICAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Oct 30 2014
    Vical Reports Third Quarter 2014 Financial Results and Progress in Key Development Programs Oct 30 2014
    Vical Announces News Release and Conference Call Schedule for Third Quarter 2014 Financial Results Oct 23 2014
    Vical Announces News Release and Conference Call Schedule for Third Quarter 2014 Financial Results Oct 23 2014
    Vical Granted Six U.S. Patents for HSV-2 Vaccines Oct 08 2014
    VICAL INC Financials Aug 08 2014
    VICAL INC Files SEC form 10-Q, Quarterly Report Aug 01 2014
    VICAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Jul 31 2014
    VICAL INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 28 2014
    Earnings Estimates Moving Higher for Vical (VICL): Time to Buy? May 15 2014
    Vical Narrows Q1 Loss May 06 2014
    VICAL INC Files SEC form 10-Q, Quarterly Report May 02 2014
    Vical's CEO Discusses Q1 2014 Results - Earnings Call Transcript May 01 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK